See how AbbVie Inc. and Cisco Systems, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$254.49
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
Cisco Systems, Inc. is the world’s largest provider of networking equipment and ranks among the largest software companies globally. Its core businesses include networking hardware and software, where it holds leading market positions, as well as cybersecurity software such as firewalls. The company also offers collaboration solutions, including its Webex suite, and observability tools. Cisco primarily relies on third-party manufacturers and maintains a large sales and marketing organization of 25,000 employees across 90 countries. In total, the company employs about 80,000 people and markets its products worldwide.